Optimal enrollment in late-stage new drug development with learning of drug's efficacy for group-sequential clinical trials
Year of publication: |
2023
|
---|---|
Authors: | Tian, Zhili ; Hazen, Gordon B. ; Li, Hong |
Published in: |
Manufacturing & service operations management : M & SOM. - Linthicum, Md. : Informs, ISSN 1526-5498, ZDB-ID 2023273-1. - Vol. 25.2023, 1, p. 88-107
|
Subject: | clinical trial management | learning of drug efficacy | market exclusivity period | new drug development management | optimal enrollment rate | R&D project management | Arzneimittel | Pharmaceuticals | Pharmakologie | Pharmacology | Pharmaindustrie | Pharmaceutical industry | Projektmanagement | Project management |
-
Clinical trials for new drug development : optimal investment and application
Kouvelis, Panos, (2017)
-
Rival signals and project selection : insights from the drug development process
Markou, Panos, (2023)
-
Pharmaceutical drug development project management
Foulkes, Janet, (2004)
- More ...
-
Wealth doesn't last 3 generations : how family businesses can maintain prosperity
Lee, Jean, (2009)
-
Siebert, Ralph, (2020)
-
Tian, Zhili, (2020)
- More ...